Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-04 5:06 pm Purchase | 2026-05-28 | 13G | Q32 BIO INC QTTB | BIOTECHNOLOGY VALUE FUND L P | 2,367,524 9.990% | 2,367,524![]() (New Position) | Filing History |
| 2026-05-29 5:51 pm Purchase | 2026-05-21 | 13G | Research Alliance Corp III RACC | BIOTECHNOLOGY VALUE FUND L P | 500,000 6.400% | 500,000![]() (New Position) | Filing History |
| 2026-05-27 4:37 pm Purchase | 2026-05-19 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BIOTECHNOLOGY VALUE FUND L P | 2,134,908 5.300% | 2,134,908![]() (New Position) | Filing History |
| 2026-05-18 5:26 pm Purchase | 2026-05-14 | 13D | XOMA ROYALTY CORPORATION COMMO XOMA | BIOTECHNOLOGY VALUE FUND L P | 7,593,303 43.300% | 5,003,000![]() (+193.14%) | Filing History |
| 2026-05-15 4:13 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | BIOTECHNOLOGY VALUE FUND L P | 1,908,722 9.990% | 1,140,522![]() (+148.47%) | Filing History |
| 2026-05-15 4:13 pm Purchase | 2026-03-31 | 13G | TSCAN THERAPEUTICS INC TCRX | BIOTECHNOLOGY VALUE FUND L P | 5,578,288 9.990% | 314,747![]() (+5.98%) | Filing History |
| 2026-05-15 4:12 pm Purchase | 2026-03-31 | 13G | NEKTAR THERAPEUTICS NKTR | BIOTECHNOLOGY VALUE FUND L P | 2,852,698 9.800% | 1,576,103![]() (+123.46%) | Filing History |
| 2026-05-15 4:11 pm Purchase | 2026-03-31 | 13G | IMAGENEBIO, INC. IMA | BIOTECHNOLOGY VALUE FUND L P | 1,110,002 9.900% | 307,900![]() (+38.39%) | Filing History |
| 2026-05-15 4:10 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BIOTECHNOLOGY VALUE FUND L P | 5,085,886 6.300% | 1,250,000![]() (+32.59%) | Filing History |
| 2026-05-15 4:09 pm Purchase | 2026-03-31 | 13G | FOGHORN THERAPEUTICS INC FHTX | BIOTECHNOLOGY VALUE FUND L P | 5,866,613 9.990% | 314,272![]() (+5.66%) | Filing History |
| 2026-05-15 4:08 pm Sale | 2026-03-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 5,346,519 9.990% | -500,762![]() (-8.56%) | Filing History |
| 2026-05-15 4:07 pm Purchase | 2026-03-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | BIOTECHNOLOGY VALUE FUND L P | 7,868,419 9.990% | 1,575,137![]() (+25.03%) | Filing History |
| 2026-05-15 4:06 pm Sale | 2026-03-31 | 13G | COMPASS THERAPEUTICS INC CMPX | BIOTECHNOLOGY VALUE FUND L P | 7,764,842 4.300% | -985,158![]() (-11.26%) | Filing History |
| 2026-05-15 4:05 pm Purchase | 2026-03-31 | 13G | CULLINAN THERAPEUTICS INC CGEM | BIOTECHNOLOGY VALUE FUND L P | 6,161,469 9.990% | 242,988![]() (+4.11%) | Filing History |
| 2026-05-15 4:04 pm Purchase | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | BIOTECHNOLOGY VALUE FUND L P | 2,347,845 9.990% | 443,588![]() (+23.29%) | Filing History |
| 2026-05-15 4:03 pm Sale | 2026-03-31 | 13G | ANNEXON INC ANNX | BIOTECHNOLOGY VALUE FUND L P | 8,698,173 5.400% | -329,605![]() (-3.65%) | Filing History |
| 2026-04-29 5:43 pm Unchanged | 2026-04-27 | 13D | XOMA ROYALTY CORPORATION COMMO XOMA | BIOTECHNOLOGY VALUE FUND L P | 2,590,303 21.400% | 0 (Unchanged) | Filing History |
| 2026-04-02 4:44 pm Sale | 2026-03-31 | 13D | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | BIOTECHNOLOGY VALUE FUND L P | 16,001,284 22.300% | -3,750,000![]() (-18.99%) | Filing History |
| 2026-02-20 6:59 pm Purchase | 2026-02-12 | 13D | IMMUNIC INC IMUX | BIOTECHNOLOGY VALUE FUND L P | 1,363,060 9.990% | 384,542![]() (+39.30%) | Filing History |
| 2026-02-18 7:49 pm Purchase | 2026-02-10 | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 1,251,788 7.600% | 1,251,788![]() (New Position) | Filing History |

